Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines
1996 ◽
Vol 39
(3)
◽
pp. 192-198
◽
Keyword(s):
1991 ◽
Vol 27
◽
pp. S41
Keyword(s):
2009 ◽
Vol 66
(2)
◽
pp. 237-243
◽
Keyword(s):
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 27
(13)
◽
pp. 2946-2952
◽
Keyword(s):
Keyword(s):